Text Size

Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal Transplantation

This study has been completed.
Sponsor:
Collaborators:
Genentech
Biogen Idec
Information provided by:
Cedars-Sinai Medical Center
ClinicalTrials.gov Identifier:
NCT00642655
First received: March 19, 2008
Last updated: March 24, 2008
Last verified: March 2008
History of Changes
No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study has been completed.
  Study Completion Date: May 2007
  Primary Completion Date: May 2007 (Final data collection date for primary outcome measure)
No publications provided by Cedars-Sinai Medical Center

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):